{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:50:48Z","timestamp":1790909448267,"version":"4.1.0"},"reference-count":140,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002863","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:38:44Z","timestamp":1069367924000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Oral beta-blockers for mild to moderate hypertension during pregnancy"],"prefix":"10.1002","volume":"2012","author":[{"given":"Laura","family":"Magee","sequence":"first","affiliation":[{"name":"British Columbia Women's Hospital and Health Centre; Departments of Internal Medicine (UBC) and Specialized Women's Health (BC Women's Hospital); 4500 Oak Street Suite 1U59 Vancouver British Columbia Canada V6H 3N1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelia","family":"Duley","sequence":"additional","affiliation":[{"name":"University of Nottingham; Nottingham Clinical Trials Unit; B39, Medical School Queen's Medical Centre Campus Nottingham UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"key":"10.1002\/14651858.CD002863-BIB0001|cit1","unstructured":"Casavilla F Vega HR Prospective and randomized study on mepindolol and alpha-methydopa efficacy in arterial hypertension (AH) treatment during pregnancy. World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil, 1988:182 Brazil 1988 182"},{"key":"10.1002\/14651858.CD002863-BIB0002|cit2","first-page":"341","article-title":"Propranolol in pregnancy. Three year prospective study","volume":"B2","author":"Livingstone","year":"1983","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0003|cit3","unstructured":"Gallery EDM Hunyor SN Saunders DM Gyory AZ A randomized trial of oxyprenolol and alpha-methyldopa in the therapy of hypertension in pregnancy. Proceedings of the 1st Congress of the International Society of Hypertension in Pregnancy;1978 September 27-29; Dublin, Ireland, 1978;88 Dublin 1978 88"},{"key":"10.1002\/14651858.CD002863-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.291.6495.563","article-title":"Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa","volume":"291","author":"Gallery","year":"1985","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002863-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.1.6178.1591","article-title":"Randomized comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy","volume":"1","author":"Gallery","year":"1979","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0006|cit6","first-page":"98","article-title":"Efficacy and safety of isradipina and atenolol in hypertensive disorders in pregnancy","volume":"19","author":"Kahhale","year":"2000","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD002863-BIB0007|cit7","first-page":"101","article-title":"A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa","volume-title":"The Investigation of labetalol in the management of hypertension in pregnancy. International Congress Series 591","author":"Redman","year":"1978"},{"key":"10.1002\/14651858.CD002863-BIB0008|cit8","unstructured":"Redman CWG Controlled trials of treatment of hypertension during pregnancy. Proceedings of the 8th International Congress of Nephrology; 1981; Athens, Greece, 1981:523-4 Athens 1981 523 4"},{"key":"10.1002\/14651858.CD002863-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/10641968009037147","article-title":"Comparison of the alpha and beta blocking drug, labetalol, and methyldopa in the treatment of moderate and severe pregnancy-induced hypertension","volume":"2","author":"Lamming","year":"1980","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"217S","DOI":"10.1111\/j.1365-2125.1979.tb04784.x","article-title":"Use of labetalol and methyldopa in pregnancy-induced hypertension","volume":"8","author":"Lamming","year":"1979","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD002863-BIB0011|cit11","unstructured":"Lamming GD Symonds EM Comparison of the alpha and beta blocking drug labetalol and aldomet in the treatment of pregnancy induced hypertension. Proceedings of the 2nd Congress of the International Society for the Study of Hypertension in Pregnancy; 1980 December 1-4; Cairo, Egypt, 1980:9 Egypt 1980 9"},{"key":"10.1002\/14651858.CD002863-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/bmj.286.6382.1927","article-title":"Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002863-BIB0013|cit13","first-page":"202","article-title":"Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"Obstetrical and Gynecological Survey"},{"key":"10.1002\/14651858.CD002863-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/bmj.285.6348.1116-b","article-title":"Atenolol: side effects in the newborn infant","volume":"285","author":"Thorley","year":"1982","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002863-BIB0015|cit15","unstructured":"Thorley KJ Randomised trial of atenolol and methyl dopa in pregnancy related hypertension. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:53 Amsterdam 1984 53"},{"key":"10.1002\/14651858.CD002863-BIB0016|cit16","first-page":"168","article-title":"Randomised trial of atenolol and methyldopa in pregnancy related hypertension","volume":"B3","author":"Thorley","year":"1984","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1471-0528.1992.tb13698.x","article-title":"A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension","volume":"99","author":"Pickles","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","article-title":"The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension","volume":"96","author":"Pickles","year":"1989","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0019|cit19","unstructured":"Pickles CJ Symonds EM Broughton Pipkin F The fetal outcome of early intervention therapy in pregnancy induced hypertension. A randomised, double-blind controlled trial of labetalol vs placebo. Proceedings of the 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:107 Montreal 1988 107"},{"key":"10.1002\/14651858.CD002863-BIB0020|cit20","first-page":"137","article-title":"Randomized and comparative study of methyldopa acebutolol and labetalol for the treatment of moderate hypertension during pregnancy","volume":"81","author":"Lardoux","year":"1988","journal-title":"Archives des Maladies du Coeur"},{"key":"10.1002\/14651858.CD002863-BIB0021|cit21","first-page":"952","article-title":"Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial","volume":"80","author":"Plouin","year":"1987","journal-title":"Archives des Maladies du Coeur"},{"key":"10.1002\/14651858.CD002863-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-0528.1988.tb06571.x","article-title":"Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial","volume":"95","author":"Plouin","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0023|cit23","first-page":"354","article-title":"Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial","volume":"84","author":"Jannet","year":"1994","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0024|cit24","first-page":"225","article-title":"Nicardipine vs metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial","volume":"49","author":"Jannet","year":"1995","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD002863-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-0528.1990.tb01738.x","article-title":"A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension","volume":"97","author":"Plouin","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0026|cit26","unstructured":"Li CY Lao TT Yu KM Wong SP Leung CF The effect of labetalol on mild pre-eclampsia. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:191 Perugia 1990 191"},{"key":"10.1002\/14651858.CD002863-BIB0027|cit27","first-page":"39","article-title":"A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension","volume":"44","author":"Oumachigui","year":"1992","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD002863-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0020-7292(86)90015-9","article-title":"Management of pregnancy-induced hypertension with pindolol - comparative study with methyldopa","volume":"24","author":"Ellenbogen","year":"1986","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD002863-BIB0029|cit29","unstructured":"Jaschevatzky OE Davidson A Ellenbogen A Anderman S Grunstein S Comparative study of pindolol and methyl dopa and transplacental cross of pindolol in PIH. Proceedings of the 5th World Congress of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK, 1986:137 1986 1986 137"},{"key":"10.1002\/14651858.CD002863-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0028-2243(86)90066-3","article-title":"Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol","volume":"22","author":"Rosenfeld","year":"1986","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD002863-BIB0031|cit31","first-page":"207","article-title":"Antihypertensive therapy in the management of hypertension in pregnancy - a clinical double-blind study of pindolol","volume":"B11","author":"Bott-Kanner","year":"1992","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0032|cit32","first-page":"119","article-title":"Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension","volume":"33","author":"Paran","year":"1995","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002863-BIB0033|cit33","first-page":"295","article-title":"A randomised trial of the antihypertensive agent, labetalol, against bed rest in pregnancy hypertension","volume":"237 Suppl 1","author":"Cameron","year":"1985","journal-title":"Archives of Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0034|cit34","first-page":"141","volume-title":"Intrauterine growth retardation and maternal labetalol treatment in a random allocation controlled study [MD thesis]","author":"Walker","year":"1992"},{"key":"10.1002\/14651858.CD002863-BIB0035|cit35","first-page":"148","article-title":"Labetalol in pregnancy-induced hypertension: fetal and maternal effects","volume-title":"International Congress Series 591","author":"Walker","year":"1982"},{"key":"10.1002\/14651858.CD002863-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/adc.59.11.1061","article-title":"First year of life after the use of atenolol in pregnancy associated hypertension","volume":"59","author":"Reynolds","year":"1984","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD002863-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9378(84)80145-3","article-title":"Obstetric aspects of the use in regnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol","volume":"150","author":"Rubin","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0038|cit38","first-page":"431","article-title":"Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension","volume":"1","author":"Rubin","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002863-BIB0039|cit39","first-page":"154","article-title":"Atenolol in the management of pregnancy associated hypertension: obstetric and paediatric aspects","volume":"133","author":"Rubin","year":"1984","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0040|cit40","unstructured":"Rubin PC Butters L Reynolds B Low RAL Atenolol in the management of pregnancy associated hypertension: obstetric and paediatric aspects. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:41 Amsterdam 1984 41"},{"key":"10.1002\/14651858.CD002863-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","article-title":"Atenolol in essential hypertension during pregnancy","volume":"301","author":"Butters","year":"1990","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002863-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/01443619209004032","article-title":"Intra-uterine growth retardation and maternal labetalol treatment in a random allocation controlled study","volume":"12","author":"Cruickshank","year":"1992","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bmj.301.6760.1103-b","article-title":"Atenolol in essential hypertension during pregnancy","volume":"301","author":"Cruickshank","year":"1990","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002863-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0028-2243(92)90192-2","article-title":"Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study","volume":"45","author":"Cruickshank","year":"1992","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD002863-BIB0045|cit45","first-page":"333","article-title":"Maternal obstetric outcome measures in a randomised controlled study of labetalol in the treatment of hypertension in pregnancy","volume":"B10","author":"Cruickshank","year":"1991","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000234649","article-title":"Intrauterine exposure to the beta-adrenergic receptor-blocking agent metoprolol and allergy","volume":"87","author":"Bjorksten","year":"1988","journal-title":"International Archives of Allergy and Immunology"},{"key":"10.1002\/14651858.CD002863-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00016348409157131","article-title":"Neonatal effect of beta-blocking drugs in pregnancy","volume":"118","author":"Finnstrom","year":"1984","journal-title":"Acta Obstetricia et Gynecologica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD002863-BIB0048|cit48","unstructured":"Ryden G Karlberg BE Wichman K Metoprolol in the treatment of hypertension in pregnancy - effect on the mother and foetus. Proceedings of the 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:38 Amsterdam 1984 38"},{"issue":"2","key":"10.1002\/14651858.CD002863-BIB0053|cit49","first-page":"195","article-title":"Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on fetal heart activity","volume":"5","author":"Wichman","year":"1986","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0049|cit50","first-page":"153","article-title":"Metoprolol in the treatment of hypertension in pregnancy - effect on the newborn baby","volume":"B3","author":"Wichman","year":"1984","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0050|cit51","unstructured":"Wichman K Ezitis J Finnstrom O Ryden G Metoprolol in the treatment of hypertension in pregnancy - effects on the newborn baby. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:40 Amsterdam 1984 40"},{"key":"10.1002\/14651858.CD002863-BIB0051|cit52","first-page":"141","article-title":"Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on the mother","volume":"B4","author":"Wichman","year":"1985","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0052|cit53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00365518409085385","article-title":"A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy","volume":"169","author":"Wichman","year":"1984","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1002\/14651858.CD002863-BIB0054|cit54","unstructured":"Hogstedt S Lindberg B Lindberg S Ludviksson K Sandstrom B Effect of metoprolol on fetal heart rate patterns during pregnancy and delivery. Proceedings of the 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 18-21 June; Amsterdam, The Netherlands, 1984:39 Amsterdam 1984 39"},{"key":"10.1002\/14651858.CD002863-BIB0055|cit55","first-page":"152","article-title":"Effect of metoprolol on fetal heart rate patterns during pregnancy and delivery","volume":"B3","author":"Hogstedt","year":"1984","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00016348509156729","article-title":"A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy","volume":"64","author":"Hogstedt","year":"1985","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD002863-BIB0057|cit57","unstructured":"Hjertberg R Belfrage P Faxelius G Lagercrantz H Neonatal outcome in infants <1500g, a randomized study of labetalol vs dihydralazine-treated hypertensive pregnant women. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:361 Perugia 1990 361"},{"key":"10.1002\/14651858.CD002863-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/jpme.1993.21.1.69","article-title":"Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment","volume":"21","author":"Hjertberg","year":"1993","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD002863-BIB0059|cit59","unstructured":"Hjertberg R Faxelius G Lagercrantz H Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. Proceedings of the 14th European Congress of Perinatal Medicine; 1994; Helsinki, Finland, 1994:18 Helsinki 1994 18"},{"key":"10.1002\/14651858.CD002863-BIB0060|cit60","first-page":"323","article-title":"A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term","volume":"70","author":"Sibai","year":"1987","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0062|cit61","unstructured":"Sibai BM The need of hypertensive drugs in management of mild to moderate pregnant hypertension. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:133 Perugia 1990 133"},{"key":"10.1002\/14651858.CD002863-BIB0061|cit62","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(90)91297-P","article-title":"A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy","volume":"162","author":"Sibai","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0063|cit63","first-page":"139","article-title":"Evaluation of antihypertensive agents in pregnancy: prospective, randomized study of mepindolol and alpha methyldopa","volume":"48","author":"Faneite A.","year":"1988","journal-title":"Revista de Obstetricia y Ginecologia de Venezuela"},{"key":"10.1002\/14651858.CD002863-BIB0064|cit64","unstructured":"Voto L Lapidus A Neira J Margulies M Atenolol vs alpha methyldopa in the treatment of hypertension in pregnancy. 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK, 1986:138 Nottingham 1986 138"},{"key":"10.1002\/14651858.CD002863-BIB0065|cit65","first-page":"95","article-title":"The use of atenolol to prevent preeclampsia and superimposed preeclampsia","volume":"46","author":"Fabregues","year":"1994","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD002863-BIB0066|cit66","unstructured":"Loquet Ph Buytaert Ph Renier M The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. Proceedings of the 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:111 Montreal 1988 111"},{"key":"10.1002\/14651858.CD002863-BIB0067|cit67","unstructured":"Davidson A Ellenbogen A Jaschevatzky O Attias Y Anderman S Grunstein S Randomized comparison of pindolol and atenolol for treatment of hypertension during pregnancy. Proceedings of the 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:99 Montreal 1988 99"},{"key":"10.1002\/14651858.CD002863-BIB0068|cit68","unstructured":"Pickles CJ Symonds EM Brinkman CR Effects of labetalol (L) vs placebo (P) on arterial pressure (AP) and forearm venous distensibility (FVD) in women with pregnancy induced hypertension (PIH). Proceedings of the 5th International Congress for the International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England, 1986:92 Nottingham 1986 92"},{"key":"10.1002\/14651858.CD002863-BIB0069|cit69","unstructured":"Tuimala RJ Hartikainen-Sorri AL Treatment of hypertension during pregnancy by beta blocking agents. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:52 Amsterdam 1984 52"},{"key":"10.1002\/14651858.CD002863-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0301-2115(95)02197-F","article-title":"Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study","volume":"62","author":"Rasanen","year":"1995","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD002863-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00004872-199917080-00019","article-title":"Short-term metabolic effects of isradipine and metoprolol in pre-eclampsia","volume":"17","author":"Laivuori","year":"1999","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0072|cit72","unstructured":"Fievet P El Esper N Gueroult JF Gueroult JC Fourner A Comparative study of clonidine and labetolol in severe hypertension induced by pregnancy. Proceedings of the 5th World Congress of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, 1986:136 Nottingham 1986 136"},{"key":"10.1002\/14651858.CD002863-BIB0073|cit73","unstructured":"Blazquez Lardoux H Leperlier E Randomized and comparative study of methyl dopa (MD), acebu-tolol (ACE) and labetalol for the treatment of moderate hypertension during pregnancy (HDP). Proceedings of the 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:100 Montreal 1988 100"},{"key":"10.1002\/14651858.CD002863-BIB0074|cit74","unstructured":"Renier M Loquet P Buytaert P The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. Proceedings of the 11th European Congress of Perinatal Medicine; 1988; Rome, Italy, 1988 Rome 1988"},{"key":"10.1002\/14651858.CD002863-BIB0075|cit75","unstructured":"Madonna O M'Pio I Labeeuw M Pozet N Zech P Evaluation of renal function in pregnant hypertensives under treatment. A comparison between methyldopa, pindolol and atenolol. Proceedings of the 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:260 Montreal 1988 260"},{"key":"10.1002\/14651858.CD002863-BIB0076|cit76","first-page":"461","article-title":"Comparison of the effects of nifedipine and atenolol in the treatment of uncomplicated gestational hypertension","volume":"44","author":"Mintz","year":"1989","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD002863-BIB0077|cit77","unstructured":"Ciraru-Vigneron N Pruna A Mintz P Bonnin P Lefevre V Comparison of nifedipine and atenolol in treatment of moderate pregnancy hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:340 Perugia 1990 340"},{"key":"10.1002\/14651858.CD002863-BIB0078|cit78","first-page":"525","article-title":"Effects of nifedipine and atenolol on the fetal-maternal circulation in moderate hypertension in pregnancy","volume":"45","author":"Bonnin","year":"1990","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD002863-BIB0079|cit79","first-page":"221","article-title":"Comparison of the effects of nifedipine and atenolol in uncomplicated gestational hypertension","volume":"47","author":"Ciraru-Vigneron","year":"1992","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD002863-BIB0080|cit80","unstructured":"Yuen FT Mo YP Yin LC Terence L A double-blind randomised placebo controlled trial of labetalol in the treatment of mild pregnancy induced hypertension. Proceedings of 2nd International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1993; Hong Kong, Singapore, 1993 Hong Kong, Singapore 1993"},{"key":"10.1002\/14651858.CD002863-BIB0081|cit81","unstructured":"Ingemarsson I Trial to assess the effects of atenolol or pindolol in pregnancy on pregnancy-induced hypertension Personal communication February 1991"},{"key":"10.1002\/14651858.CD002863-BIB0082|cit82","unstructured":"Paran E Maisner I Holzberg G Mazor M Zmora E Biale Y Beta-blocker treatment of PIH correlated with uteroplacental blood flow measurement. Proceedings of the 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:109 Montreal 1988 109"},{"key":"10.1002\/14651858.CD002863-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jcu.1870200205","article-title":"Flow velocity analysis of umbilical and uterine artery flow in pre-eclampsia treated with propranolol or pindolol","volume":"20","author":"Meizner","year":"1992","journal-title":"Journal of Clinical Ultrasound"},{"key":"10.1002\/14651858.CD002863-BIB0084|cit84","unstructured":"Bar J Hirsch M Friedman S Fuchs J Ovadia J Bott-Kanner G The effect of beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancies. Proceedings of the 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994; Sydney, Australia, 1994:155 Sydney 1994 155"},{"key":"10.1002\/14651858.CD002863-BIB0085|cit85","unstructured":"Martinelli P Ferrara LA Pasanisi F Arpaia F Paladini D Mancini M Nifedipine and atenolol in the treatment of pregnancy associated hypertension. Proceedings of the 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 7-10 July; Nottingham, England, 1986:128 Nottingham 1986 128"},{"key":"10.1002\/14651858.CD002863-BIB0086|cit86","unstructured":"Orlandi C Marlettini MG Cassani A Crippa S Antihypertensive therapy in pregnancy. Proceedings of the 11th European Congress of Perinatal Medicine; 1988; Rome, Italy, 1988:271 Rome 1988 271"},{"key":"10.1002\/14651858.CD002863-BIB0087|cit87","first-page":"684","article-title":"Randomized comparison of calcium antagonists and beta-blockers in the treatment of pregnancy-induced hypertension","volume":"45","author":"Marlettini","year":"1990","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD002863-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0020-7292(95)02351-C","article-title":"Labetalol vs methyldopa in the treatment of pregnancy-induced hypertension","volume":"49","author":"El-Qarmalawi","year":"1995","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD002863-BIB0089|cit89","unstructured":"Lule J Aspirin and methyldopa for moderate hypertension in pregnancy Personal communication"},{"key":"10.1002\/14651858.CD002863-BIB0090|cit90","unstructured":"Harper A Murnaghan GA Erskine L Ritchie JK Response of fetal umbilical artery time velocity waveforms to antihypertensive drugs. Proceedings of the British Congress of Obstetrics and Gynaecology; 1986; UK, 1986:33 1986 33"},{"key":"10.1002\/14651858.CD002863-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.1991.tb10339.x","article-title":"Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol","volume":"98","author":"Harper","year":"1991","journal-title":"British Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0092|cit92","unstructured":"Pello L Multicentre trial of treatment of hypertension in pregnancy Personal communication"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0093|cit93","first-page":"156","article-title":"Increased blood viscosity in pre-eclampsia: effect of treatment with labetolol","volume":"50","author":"Lang","year":"1983","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002863-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1447-0756.1998.tb00080.x","article-title":"Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy","volume":"24","author":"Yin","year":"1998","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD002863-BIB0095|cit95","unstructured":"Torres Pons PJ Roca M Codina C Cobo E Cararach V Gonzalez-Merlo J Labetalol in the treatment of mild hypertension in pregnancy. A double blind controlled trial. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:102 Montreal 1988 102"},{"key":"10.1002\/14651858.CD002863-BIB0096|cit96","unstructured":"Wichman K Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on the newborn baby Personal communication"},{"key":"10.1002\/14651858.CD002863-BIB0097|cit97","unstructured":"Wichman K Metoprolol in the treatment of mild to moderate hypertension in pregnancy - two-year follow-up study of the infants Personal communication"},{"key":"10.1002\/14651858.CD002863-BIB0098|cit98","unstructured":"Montan S Ingemarsson I Marsal K Sjoberg NO Negative influence of atenolol compared with pindolol on fetal hemodynamics in pregnancies with hypertension - a controlled study. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:192 Perugia 1990 192"},{"key":"10.1002\/14651858.CD002863-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bmj.304.6832.946","article-title":"Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics","volume":"304","author":"Montan","year":"1992","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002863-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00016349309021152","article-title":"Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants","volume":"72","author":"Hjertberg","year":"1993","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD002863-BIB0101|cit101","first-page":"557","article-title":"The effect of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies","volume":"57","author":"Welt","year":"1981","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0102|cit102","unstructured":"Welt SI The use of prophylactic antihypertensive therapy in chronic hypertension in pregnancy Personal communication"},{"key":"10.1002\/14651858.CD002863-BIB0103|cit103","unstructured":"Weiner CP Trial to evaluate oral hypotensive agents in early onset preeclampsia Personal communication November 1990"},{"key":"10.1002\/14651858.CD002863-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-0528.1991.tb13387.x","article-title":"The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment","volume":"98","author":"Blake","year":"1991","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0105|cit105","volume-title":"Estudo prospectivo comparativo da isradipina e atenolol no tratamento de gestantes hipertensas [Prospective, comparative study of isradipine and atenolol for the treatment of hypertensive pregnant women] [thesis]","author":"Alves","year":"1998"},{"key":"10.1002\/14651858.CD002863-BIB0106|cit106","unstructured":"August P Treatment targets for chronic hypertension in pregnancy http:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT00194974 (accessed 3 June 2012) 2005"},{"key":"10.1002\/14651858.CD002863-BIB0107|cit107","unstructured":"Centeno DMW Urbina JCP De Las Salas M Fuenmayor AJ Effect of carvedilol in the treatment of hypertension in pregnant women XLIV ERA-EDTA Congress; 2007 June 21-24; Barcelona, Spain 2007 Poster no: FP078"},{"issue":"5","key":"10.1002\/14651858.CD002863-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1590\/S0041-87812004000500004","article-title":"Glycemia in newborns of hypertensive mothers according to maternal treatment","volume":"59","author":"Darcie","year":"2004","journal-title":"Revista do Hospital das Clinicas"},{"issue":"3","key":"10.1002\/14651858.CD002863-BIB0109|cit109","first-page":"157","article-title":"Comparative study with pindolol and methildopa in pregnant women with chronic hypertension","volume":"98","author":"Freire","year":"1988","journal-title":"Jornal Brasileiro de Ginecologia"},{"issue":"2","key":"10.1002\/14651858.CD002863-BIB0110|cit110","first-page":"232","article-title":"Antihypertensive therapy in pregnancy [abstract]","volume":"26","author":"Gallery","year":"1984","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0111|cit111","first-page":"3","article-title":"Labetalol vs alpha methyldopa in the treatment of hypertension in pregnancy","volume":"13","author":"Gonzalez","year":"1997","journal-title":"Boletin Medico de Postgrado"},{"key":"10.1002\/14651858.CD002863-BIB0112|cit112","unstructured":"Hameed AB A comparison of compliance between clonidine patch and methyldopa for the treament of chronic hypertension in pregnancy ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/) (accessed 20 February 2008) 2008"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0113|cit113","first-page":"19","article-title":"Growth of newborn of the mothers with hypertension during the first year of life: influence of therapeutics in pregnancy","volume":"21","author":"Leone","year":"2003","journal-title":"Revista Paulista de Pediatria"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10641958509031658","article-title":"Effect of metoprolol in combination with hydralazine on fetal heart rate patterns during hypertensive pregnancy and delivery","volume":"4","author":"Lindeberg","year":"1985","journal-title":"Clinical & Experimental Hypertension - Part B, Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD002863-BIB0115|cit115","unstructured":"Osvaldo A Reyes T Hydralazine vs. Labetalol for the management of hypertensive crisis in patients with hypertensive disorders of pregnancy. a randomized controlled trial http:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT01538875"},{"key":"10.1002\/14651858.CD002863-BIB0116|cit116","unstructured":"Pandey K Gupta N Gupta R Gupta S Comparing obstetric outcome using labetalol\/methyldopa in pregnancy induced hypertension 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India 2011 46"},{"key":"10.1002\/14651858.CD002863-BIB0117|cit117","unstructured":"Paran E Baile Y Holzberg G Masor M Zmora E Insler V Treatment of hypertension in pregnancy: different regime, different outcome 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26, Montreal, Quebec, Canada 1988 105"},{"key":"10.1002\/14651858.CD002863-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2165\/00003495-198300252-00061","article-title":"Atenolol in the management of hypertension during pregnancy","volume":"25","author":"Rubin","year":"1983","journal-title":"Drugs"},{"issue":"9-10","key":"10.1002\/14651858.CD002863-BIB0119|cit119","first-page":"335","article-title":"Treatment of hypertension in pregnancy: atenolol versus alpha-methyldopa","volume":"43","author":"Voto","year":"1985","journal-title":"Obstetricia y Ginecologia Latino-Americanas"},{"issue":"3","key":"10.1002\/14651858.CD002863-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10641959009012940","article-title":"Effectiveness of antihypertensive drugs in the treatment of hypertension in pregnancy","volume":"9","author":"Voto","year":"1990","journal-title":"Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002863-BIB0121|cit121","first-page":"9","article-title":"First interim report on the labetalol versus magnesium sulfate for the prevention of eclampsia trial (LAMPET) [abstract]","volume":"23","author":"Warren","year":"2004","journal-title":"Hypertension in Pregnancy"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0122|cit122","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy (Cochrane Review)","author":"Abalos","year":"2002","journal-title":"The Cochrane Library"},{"issue":"2","key":"10.1002\/14651858.CD002863-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1479-828X.2000.tb01136.x","article-title":"The detection, investigation and management of hypertension in pregnancy: executive summary","volume":"40","author":"Brown","year":"2000","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002863-BIB0124|cit124","first-page":"512","article-title":"Pharmacological prevention and treatment of hypertensive disorders in pregnancy","volume-title":"Effective Care in Pregnancy and Childbirth","author":"Collins","year":"1989"},{"key":"10.1002\/14651858.CD002863-BIB0125|cit125","volume-title":"Report on Confidential Inquiries into Maternal Deaths in the United Kingdom 1994-96","author":"Northern","year":"1998"},{"key":"10.1002\/14651858.CD002863-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-0528.1992.tb13818.x","article-title":"Maternal mortality and hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean","volume":"99","author":"Duley","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0127|cit127","article-title":"Drugs for rapid treatment of very high blood pressure during pregnancy (Cochrane Review)","author":"Duley","year":"2002","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002863-BIB0128|cit128","first-page":"725","article-title":"Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension","volume":"93","author":"Easterling","year":"1999","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD002863-BIB0129|cit129","article-title":"Antiplatelet agents for preventing and treating pre-eclampsia (Cochrane Review)","author":"Knight","year":"2002","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002863-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"As assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002863-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension","volume":"12","author":"Lydakis","year":"1999","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD002863-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report on High Blood Pressure in Pregnancy","volume":"183","author":"National High Blood Pressure Education Program Working Group","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002863-BIB0133|cit133","first-page":"515","article-title":"Hypertension in pregnancy","volume-title":"Textbook of obstetrics","author":"Redman","year":"1989"},{"key":"10.1002\/14651858.CD002863-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-2243(93)90032-8","article-title":"Management of severe, early pre-eclampsia: is conservative management justified?","volume":"51","author":"Redman","year":"1993","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD002863-BIB0135|cit135","unstructured":"The Cochrane Collaboration Review Manager (RevMan) [Computer program] 2000"},{"key":"10.1002\/14651858.CD002863-BIB0136|cit136","first-page":"1245","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","author":"Rey","year":"1997","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD002863-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"Dadelszen","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002863-BIB0138|cit138","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy (Cochrane Review)","author":"Magee","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002863-BIB0139|cit139","unstructured":"Collins R Duley L Beta-blockers vs methyldopa in the treatment of pre-eclampsia. [ revised 21 March 1994] In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995"},{"key":"10.1002\/14651858.CD002863-BIB0140|cit140","unstructured":"Collins R Duley L Beta-blockers in the treatment of pre-eclampsia. [ revised 21 April 1994] In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002863\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:47:25Z","timestamp":1775249245000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002863"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":140,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002863","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,21]]}}}